Added to YB: 2026-01-09
Pitch date: 2026-01-05
GUARD.ST [neutral]
Guard Therapeutics International AB (publ)
+12.45%
current return
Author Info
Liquidation stocks is focused on liquidation and wind downs of listed stocks. I cover USA, Canada, UK, Europe, Australia, NZL, Japan, Hong Kong and other countries. Sign up for the newsletter.
Company Info
Guard Therapeutics International AB (publ), a pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden.
Market Cap
SEK 27.4M
Pitch Price
SEK 1.36
Price Target
2.76 (+80%)
Dividend
N/A
EV/EBITDA
N/A
P/E
-0.18
EV/Sales
N/A
Sector
Biotechnology
Category
special_situation
Liquidations Newsletter - Potential Liquidations: Guard Therapeutics International AB
GUARD.ST (liquidation update): Clinical-stage biotech discontinued main kidney program, insufficient cash for other programs. Board conducting strategic review for merger/RTO; if unsuccessful will delist & liquidate. 3.46 SEK/share cash vs 2.76 SEK NAV book value. Liquidation value play.
Read full article (1 min)